Rigel Pharmaceuticals, Inc. (RIGL) Posts Q2 Loss of 26c/Share
Tweet
Share
E-mailGet Alerts RIGL Hot Sheet
Price: $38.69 --0%
Financial Fact:
Total costs and expenses: 26.5M
Today's EPS Names:
DTGI, OCCI, MAYS, More
Financial Fact:
Total costs and expenses: 26.5M
Today's EPS Names:
DTGI, OCCI, MAYS, More
Join SI Premium – FREE
Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) reported Q2 EPS of ($0.26), $0.04 better than the analyst estimate of ($0.30). Revenue for the quarter came in at $1.4 million versus the consensus estimate of $530 thousand.
For earnings history and earnings-related data on Rigel Pharmaceuticals, Inc. (RIGL) click here.
For earnings history and earnings-related data on Rigel Pharmaceuticals, Inc. (RIGL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- onsemi downgraded by TD Cowen after Synaptics deal clouds growth story
- Taiwan Semiconductor Manufacturing Co. Ltd. (2330:TT) (TSM) PT Raised to NT$3,400 at UBS
- JPMorgan Starts TIME dotCom Berhad (TDC:MK) at Overweight
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
